Castleman disease (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Castleman disease" in English language version.

refsWebsite

Global rank English rank

25nih.gov

4^th place

18doi.org

2^nd place

10worldcat.org

5^th place

6semanticscholar.org

11^th place

8^th place

2cdcn.org

low place

1mayoclinic.org

1,610^th place

1,279^th place

cdcn.org

"Castleman Disease Collaborative Network". CDCN. Retrieved 2019-12-30.
"Castleman Disease Collaborative Network". CDCN. Retrieved 2019-12-30.

doi.org

Yu, Li; Tu, Meifeng; Cortes, Jorge; Xu-Monette, Zijun Y.; Miranda, Roberto N.; Zhang, Jun; Orlowski, Robert Z.; Neelapu, Sattva; Boddu, Prajwal C.; Akosile, Mary A.; Uldrick, Thomas S. (2017-03-23). "Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease". Blood. 129 (12): 1658–1668. doi:10.1182/blood-2016-11-748855. ISSN 0006-4971. PMC 5364343. PMID 28100459.
Fajgenbaum DC, Shilling D (February 2018). "Castleman Disease Pathogenesis". Hematology/Oncology Clinics of North America. 32 (1): 11–21. doi:10.1016/j.hoc.2017.09.002. PMID 29157613.
Sarmiento Bustamante, Mateo; Shyamsundar, Saishravan; Coren, Freda R.; Bagg, Adam; Srkalovic, Gordan; Alapat, Daisy; van Rhee, Frits; Lim, Megan S.; Lechowicz, Mary Jo; Brandstadter, Joshua D.; Pierson, Sheila K.; Fajgenbaum, David C. (November 2023). "Ongoing symptoms following complete surgical excision in unicentric Castleman disease". American Journal of Hematology. 98 (11): E334–E337. doi:10.1002/ajh.27065. ISSN 1096-8652. PMC 10998479. PMID 37635628.
Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L (January 2018). "The full spectrum of Castleman disease: 273 patients studied over 20 years". British Journal of Haematology. 180 (2): 206–216. doi:10.1111/bjh.15019. PMID 29143319.
Talat N, Belgaumkar AP, Schulte KM (April 2012). "Surgery in Castleman's disease: a systematic review of 404 published cases". Annals of Surgery. 255 (4): 677–84. doi:10.1097/SLA.0b013e318249dcdc. PMID 22367441. S2CID 7553851.
Fajgenbaum, David C.; Uldrick, Thomas S.; Bagg, Adam; Frank, Dale; Wu, David; Srkalovic, Gordan; Simpson, David; Liu, Amy Y.; Menke, David; Chandrakasan, Shanmuganathan; Lechowicz, Mary Jo (2017-03-23). "International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. ISSN 0006-4971. PMC 5364342. PMID 28087540.
Carbone, Antonino; Borok, Margaret; Damania, Blossom; Gloghini, Annunziata; Polizzotto, Mark N.; Jayanthan, Raj K.; Fajgenbaum, David C.; Bower, Mark (2021-11-25). "Castleman disease". Nature Reviews Disease Primers. 7 (1): 84. doi:10.1038/s41572-021-00317-7. ISSN 2056-676X. PMC 9584164. PMID 34824298. S2CID 242999200.
Fajgenbaum, David C. (2018-11-29). "Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease". Blood. 132 (22): 2323–2330. doi:10.1182/blood-2018-05-848671. ISSN 0006-4971. PMC 6265649. PMID 30487129.
Iwaki, Noriko; Fajgenbaum, David C.; Nabel, Christopher S.; Gion, Yuka; Kondo, Eisei; Kawano, Mitsuhiro; Masunari, Taro; Yoshida, Isao; Moro, Hiroshi; Nikkuni, Koji; Takai, Kazue (2016). "Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease". American Journal of Hematology. 91 (2): 220–226. doi:10.1002/ajh.24242. ISSN 1096-8652. PMID 26805758. S2CID 521845.
Fujimoto, Shino; Sakai, Tomoyuki; Kawabata, Hiroshi; Kurose, Nozomu; Yamada, Sohsuke; Takai, Kazue; Aoki, Sadao; Kuroda, Junya; Ide, Makoto; Setoguchi, Keigo; Tsukamoto, Norifumi (September 2019). "Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?". American Journal of Hematology. 94 (9): 975–983. doi:10.1002/ajh.25554. ISSN 0361-8609. PMID 31222819. S2CID 195192296.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. (March 2017). "International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. PMC 5364342. PMID 28087540.
Keller AR, Hochholzer L, Castleman B (March 1972). "Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations". Cancer. 29 (3): 670–83. doi:10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#. PMID 4551306. S2CID 196375825.
Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC (April 2016). "Idiopathic multicentric Castleman's disease: a systematic literature review". The Lancet. Haematology. 3 (4): e163–75. doi:10.1016/S2352-3026(16)00006-5. PMID 27063975.
Castleman, B.; Iverson, L.; Menendez, V. P. (July 1956). "Localized mediastinal lymphnode hyperplasia resembling thymoma". Cancer. 9 (4): 822–830. doi:10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. ISSN 0008-543X. PMID 13356266.
Chen KT (April 1984). "Multicentric Castleman's disease and Kaposi's sarcoma". The American Journal of Surgical Pathology. 8 (4): 287–93. doi:10.1097/00000478-198404000-00006. PMID 6711739. S2CID 38948699.
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. (August 1995). "Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease". Blood. 86 (4): 1276–80. doi:10.1182/blood.V86.4.1276.bloodjournal8641276. PMID 7632932.
van Rhee, Frits; Voorhees, Peter; Dispenzieri, Angela; Fosså, Alexander; Srkalovic, Gordan; Ide, Makoto; Munshi, Nikhil; Schey, Stephen; Streetly, Matthew (2018-09-04). "International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease". Blood. 132 (20): blood-2018-07-862334. doi:10.1182/blood-2018-07-862334. ISSN 1528-0020. PMC 6238190. PMID 30181172.
Fajgenbaum, David C.; Ruth, Jason R.; Kelleher, Dermot; Rubenstein, Arthur H. (April 2016). "The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research". The Lancet Haematology. 3 (4): e150–152. doi:10.1016/S2352-3026(16)00007-7. ISSN 2352-3026. PMID 27063967.

mayoclinic.org

"Castleman disease". mayoclinic.org. Mayo Clinic. Retrieved 5 June 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Yu, Li; Tu, Meifeng; Cortes, Jorge; Xu-Monette, Zijun Y.; Miranda, Roberto N.; Zhang, Jun; Orlowski, Robert Z.; Neelapu, Sattva; Boddu, Prajwal C.; Akosile, Mary A.; Uldrick, Thomas S. (2017-03-23). "Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease". Blood. 129 (12): 1658–1668. doi:10.1182/blood-2016-11-748855. ISSN 0006-4971. PMC 5364343. PMID 28100459.
Fajgenbaum DC, Shilling D (February 2018). "Castleman Disease Pathogenesis". Hematology/Oncology Clinics of North America. 32 (1): 11–21. doi:10.1016/j.hoc.2017.09.002. PMID 29157613.
Sarmiento Bustamante, Mateo; Shyamsundar, Saishravan; Coren, Freda R.; Bagg, Adam; Srkalovic, Gordan; Alapat, Daisy; van Rhee, Frits; Lim, Megan S.; Lechowicz, Mary Jo; Brandstadter, Joshua D.; Pierson, Sheila K.; Fajgenbaum, David C. (November 2023). "Ongoing symptoms following complete surgical excision in unicentric Castleman disease". American Journal of Hematology. 98 (11): E334–E337. doi:10.1002/ajh.27065. ISSN 1096-8652. PMC 10998479. PMID 37635628.
Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L (January 2018). "The full spectrum of Castleman disease: 273 patients studied over 20 years". British Journal of Haematology. 180 (2): 206–216. doi:10.1111/bjh.15019. PMID 29143319.
Talat N, Belgaumkar AP, Schulte KM (April 2012). "Surgery in Castleman's disease: a systematic review of 404 published cases". Annals of Surgery. 255 (4): 677–84. doi:10.1097/SLA.0b013e318249dcdc. PMID 22367441. S2CID 7553851.
Fajgenbaum, David C.; Uldrick, Thomas S.; Bagg, Adam; Frank, Dale; Wu, David; Srkalovic, Gordan; Simpson, David; Liu, Amy Y.; Menke, David; Chandrakasan, Shanmuganathan; Lechowicz, Mary Jo (2017-03-23). "International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. ISSN 0006-4971. PMC 5364342. PMID 28087540.
Carbone, Antonino; Borok, Margaret; Damania, Blossom; Gloghini, Annunziata; Polizzotto, Mark N.; Jayanthan, Raj K.; Fajgenbaum, David C.; Bower, Mark (2021-11-25). "Castleman disease". Nature Reviews Disease Primers. 7 (1): 84. doi:10.1038/s41572-021-00317-7. ISSN 2056-676X. PMC 9584164. PMID 34824298. S2CID 242999200.
Fajgenbaum, David C. (2018-11-29). "Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease". Blood. 132 (22): 2323–2330. doi:10.1182/blood-2018-05-848671. ISSN 0006-4971. PMC 6265649. PMID 30487129.
Iwaki, Noriko; Fajgenbaum, David C.; Nabel, Christopher S.; Gion, Yuka; Kondo, Eisei; Kawano, Mitsuhiro; Masunari, Taro; Yoshida, Isao; Moro, Hiroshi; Nikkuni, Koji; Takai, Kazue (2016). "Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease". American Journal of Hematology. 91 (2): 220–226. doi:10.1002/ajh.24242. ISSN 1096-8652. PMID 26805758. S2CID 521845.
Fujimoto, Shino; Sakai, Tomoyuki; Kawabata, Hiroshi; Kurose, Nozomu; Yamada, Sohsuke; Takai, Kazue; Aoki, Sadao; Kuroda, Junya; Ide, Makoto; Setoguchi, Keigo; Tsukamoto, Norifumi (September 2019). "Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?". American Journal of Hematology. 94 (9): 975–983. doi:10.1002/ajh.25554. ISSN 0361-8609. PMID 31222819. S2CID 195192296.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. (March 2017). "International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. PMC 5364342. PMID 28087540.
Keller AR, Hochholzer L, Castleman B (March 1972). "Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations". Cancer. 29 (3): 670–83. doi:10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#. PMID 4551306. S2CID 196375825.
Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC (April 2016). "Idiopathic multicentric Castleman's disease: a systematic literature review". The Lancet. Haematology. 3 (4): e163–75. doi:10.1016/S2352-3026(16)00006-5. PMID 27063975.
Castleman, B.; Iverson, L.; Menendez, V. P. (July 1956). "Localized mediastinal lymphnode hyperplasia resembling thymoma". Cancer. 9 (4): 822–830. doi:10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. ISSN 0008-543X. PMID 13356266.
Chen KT (April 1984). "Multicentric Castleman's disease and Kaposi's sarcoma". The American Journal of Surgical Pathology. 8 (4): 287–93. doi:10.1097/00000478-198404000-00006. PMID 6711739. S2CID 38948699.
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. (August 1995). "Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease". Blood. 86 (4): 1276–80. doi:10.1182/blood.V86.4.1276.bloodjournal8641276. PMID 7632932.
van Rhee, Frits; Voorhees, Peter; Dispenzieri, Angela; Fosså, Alexander; Srkalovic, Gordan; Ide, Makoto; Munshi, Nikhil; Schey, Stephen; Streetly, Matthew (2018-09-04). "International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease". Blood. 132 (20): blood-2018-07-862334. doi:10.1182/blood-2018-07-862334. ISSN 1528-0020. PMC 6238190. PMID 30181172.
Fajgenbaum, David C.; Ruth, Jason R.; Kelleher, Dermot; Rubenstein, Arthur H. (April 2016). "The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research". The Lancet Haematology. 3 (4): e150–152. doi:10.1016/S2352-3026(16)00007-7. ISSN 2352-3026. PMID 27063967.

ncbi.nlm.nih.gov

Yu, Li; Tu, Meifeng; Cortes, Jorge; Xu-Monette, Zijun Y.; Miranda, Roberto N.; Zhang, Jun; Orlowski, Robert Z.; Neelapu, Sattva; Boddu, Prajwal C.; Akosile, Mary A.; Uldrick, Thomas S. (2017-03-23). "Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease". Blood. 129 (12): 1658–1668. doi:10.1182/blood-2016-11-748855. ISSN 0006-4971. PMC 5364343. PMID 28100459.
Sarmiento Bustamante, Mateo; Shyamsundar, Saishravan; Coren, Freda R.; Bagg, Adam; Srkalovic, Gordan; Alapat, Daisy; van Rhee, Frits; Lim, Megan S.; Lechowicz, Mary Jo; Brandstadter, Joshua D.; Pierson, Sheila K.; Fajgenbaum, David C. (November 2023). "Ongoing symptoms following complete surgical excision in unicentric Castleman disease". American Journal of Hematology. 98 (11): E334–E337. doi:10.1002/ajh.27065. ISSN 1096-8652. PMC 10998479. PMID 37635628.
Fajgenbaum, David C.; Uldrick, Thomas S.; Bagg, Adam; Frank, Dale; Wu, David; Srkalovic, Gordan; Simpson, David; Liu, Amy Y.; Menke, David; Chandrakasan, Shanmuganathan; Lechowicz, Mary Jo (2017-03-23). "International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. ISSN 0006-4971. PMC 5364342. PMID 28087540.
Carbone, Antonino; Borok, Margaret; Damania, Blossom; Gloghini, Annunziata; Polizzotto, Mark N.; Jayanthan, Raj K.; Fajgenbaum, David C.; Bower, Mark (2021-11-25). "Castleman disease". Nature Reviews Disease Primers. 7 (1): 84. doi:10.1038/s41572-021-00317-7. ISSN 2056-676X. PMC 9584164. PMID 34824298. S2CID 242999200.
Fajgenbaum, David C. (2018-11-29). "Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease". Blood. 132 (22): 2323–2330. doi:10.1182/blood-2018-05-848671. ISSN 0006-4971. PMC 6265649. PMID 30487129.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. (March 2017). "International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. PMC 5364342. PMID 28087540.
van Rhee, Frits; Voorhees, Peter; Dispenzieri, Angela; Fosså, Alexander; Srkalovic, Gordan; Ide, Makoto; Munshi, Nikhil; Schey, Stephen; Streetly, Matthew (2018-09-04). "International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease". Blood. 132 (20): blood-2018-07-862334. doi:10.1182/blood-2018-07-862334. ISSN 1528-0020. PMC 6238190. PMID 30181172.

semanticscholar.org

api.semanticscholar.org

Talat N, Belgaumkar AP, Schulte KM (April 2012). "Surgery in Castleman's disease: a systematic review of 404 published cases". Annals of Surgery. 255 (4): 677–84. doi:10.1097/SLA.0b013e318249dcdc. PMID 22367441. S2CID 7553851.
Carbone, Antonino; Borok, Margaret; Damania, Blossom; Gloghini, Annunziata; Polizzotto, Mark N.; Jayanthan, Raj K.; Fajgenbaum, David C.; Bower, Mark (2021-11-25). "Castleman disease". Nature Reviews Disease Primers. 7 (1): 84. doi:10.1038/s41572-021-00317-7. ISSN 2056-676X. PMC 9584164. PMID 34824298. S2CID 242999200.
Iwaki, Noriko; Fajgenbaum, David C.; Nabel, Christopher S.; Gion, Yuka; Kondo, Eisei; Kawano, Mitsuhiro; Masunari, Taro; Yoshida, Isao; Moro, Hiroshi; Nikkuni, Koji; Takai, Kazue (2016). "Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease". American Journal of Hematology. 91 (2): 220–226. doi:10.1002/ajh.24242. ISSN 1096-8652. PMID 26805758. S2CID 521845.
Fujimoto, Shino; Sakai, Tomoyuki; Kawabata, Hiroshi; Kurose, Nozomu; Yamada, Sohsuke; Takai, Kazue; Aoki, Sadao; Kuroda, Junya; Ide, Makoto; Setoguchi, Keigo; Tsukamoto, Norifumi (September 2019). "Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?". American Journal of Hematology. 94 (9): 975–983. doi:10.1002/ajh.25554. ISSN 0361-8609. PMID 31222819. S2CID 195192296.
Keller AR, Hochholzer L, Castleman B (March 1972). "Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations". Cancer. 29 (3): 670–83. doi:10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#. PMID 4551306. S2CID 196375825.
Chen KT (April 1984). "Multicentric Castleman's disease and Kaposi's sarcoma". The American Journal of Surgical Pathology. 8 (4): 287–93. doi:10.1097/00000478-198404000-00006. PMID 6711739. S2CID 38948699.

worldcat.org

search.worldcat.org

Yu, Li; Tu, Meifeng; Cortes, Jorge; Xu-Monette, Zijun Y.; Miranda, Roberto N.; Zhang, Jun; Orlowski, Robert Z.; Neelapu, Sattva; Boddu, Prajwal C.; Akosile, Mary A.; Uldrick, Thomas S. (2017-03-23). "Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease". Blood. 129 (12): 1658–1668. doi:10.1182/blood-2016-11-748855. ISSN 0006-4971. PMC 5364343. PMID 28100459.
Sarmiento Bustamante, Mateo; Shyamsundar, Saishravan; Coren, Freda R.; Bagg, Adam; Srkalovic, Gordan; Alapat, Daisy; van Rhee, Frits; Lim, Megan S.; Lechowicz, Mary Jo; Brandstadter, Joshua D.; Pierson, Sheila K.; Fajgenbaum, David C. (November 2023). "Ongoing symptoms following complete surgical excision in unicentric Castleman disease". American Journal of Hematology. 98 (11): E334–E337. doi:10.1002/ajh.27065. ISSN 1096-8652. PMC 10998479. PMID 37635628.
Fajgenbaum, David C.; Uldrick, Thomas S.; Bagg, Adam; Frank, Dale; Wu, David; Srkalovic, Gordan; Simpson, David; Liu, Amy Y.; Menke, David; Chandrakasan, Shanmuganathan; Lechowicz, Mary Jo (2017-03-23). "International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease". Blood. 129 (12): 1646–1657. doi:10.1182/blood-2016-10-746933. ISSN 0006-4971. PMC 5364342. PMID 28087540.
Carbone, Antonino; Borok, Margaret; Damania, Blossom; Gloghini, Annunziata; Polizzotto, Mark N.; Jayanthan, Raj K.; Fajgenbaum, David C.; Bower, Mark (2021-11-25). "Castleman disease". Nature Reviews Disease Primers. 7 (1): 84. doi:10.1038/s41572-021-00317-7. ISSN 2056-676X. PMC 9584164. PMID 34824298. S2CID 242999200.
Fajgenbaum, David C. (2018-11-29). "Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease". Blood. 132 (22): 2323–2330. doi:10.1182/blood-2018-05-848671. ISSN 0006-4971. PMC 6265649. PMID 30487129.
Iwaki, Noriko; Fajgenbaum, David C.; Nabel, Christopher S.; Gion, Yuka; Kondo, Eisei; Kawano, Mitsuhiro; Masunari, Taro; Yoshida, Isao; Moro, Hiroshi; Nikkuni, Koji; Takai, Kazue (2016). "Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease". American Journal of Hematology. 91 (2): 220–226. doi:10.1002/ajh.24242. ISSN 1096-8652. PMID 26805758. S2CID 521845.
Fujimoto, Shino; Sakai, Tomoyuki; Kawabata, Hiroshi; Kurose, Nozomu; Yamada, Sohsuke; Takai, Kazue; Aoki, Sadao; Kuroda, Junya; Ide, Makoto; Setoguchi, Keigo; Tsukamoto, Norifumi (September 2019). "Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?". American Journal of Hematology. 94 (9): 975–983. doi:10.1002/ajh.25554. ISSN 0361-8609. PMID 31222819. S2CID 195192296.
Castleman, B.; Iverson, L.; Menendez, V. P. (July 1956). "Localized mediastinal lymphnode hyperplasia resembling thymoma". Cancer. 9 (4): 822–830. doi:10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. ISSN 0008-543X. PMID 13356266.
van Rhee, Frits; Voorhees, Peter; Dispenzieri, Angela; Fosså, Alexander; Srkalovic, Gordan; Ide, Makoto; Munshi, Nikhil; Schey, Stephen; Streetly, Matthew (2018-09-04). "International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease". Blood. 132 (20): blood-2018-07-862334. doi:10.1182/blood-2018-07-862334. ISSN 1528-0020. PMC 6238190. PMID 30181172.
Fajgenbaum, David C.; Ruth, Jason R.; Kelleher, Dermot; Rubenstein, Arthur H. (April 2016). "The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research". The Lancet Haematology. 3 (4): e150–152. doi:10.1016/S2352-3026(16)00007-7. ISSN 2352-3026. PMID 27063967.